Neogen Stock Investor Sentiment

NEOG Stock  USD 12.14  0.19  1.54%   
Roughly 63% of all Neogen's stockholders are looking to take a long position. The analysis of overall sentiment of trading Neogen stock suggests that some investors are interested at this time. The current market sentiment, together with Neogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Neogen stock news signals to limit their universe of possible portfolio assets.
  

Neogen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Neogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Neogen Maximum Pain Price Across January 17th 2025 Option Contracts

Neogen's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Neogen close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Neogen's options.
over a year ago at Macroaxis         
Should you exit your stake in Neogen (NASDAQ:NEOG)?
Macroaxis News
few days ago at insidermonkey.com         
Why Is Qiagen N.V. Among the Top CRISPR Stocks to Invest In?
insidermonkey News
over two weeks ago at gurufocus.com         
Qiagen NV Launches AI-Driven IPA Interpret for Enhanced Biological Data Analysis
Gurufocus Stories at Macroaxis
over three weeks ago at simplywall.st         
Qiagen Seems To Use Debt Rather Sparingly
Simply Wall St News at Macroaxis
over three weeks ago at kalkinemedia.com         
Global Multiplex Assay Market CAGR of 14.6 percent Size, Growth Drivers and Forecast 2024-2031 Lumin...
news
over six months ago at news.google.com         
Olink Holding AB Position Trimmed by Principal Financial Group Inc. - Defense World
Google News at Macroaxis
over six months ago at globenewswire.com         
Notice to attend the Extra General Meeting of Olink Holding AB
Macroaxis News: globenewswire.com
over three weeks ago at www.macroaxis.com         
Disposition of 15000 shares by Joseph Monahan of Aclaris Therapeutics subject to Rule 16b-3
Macroaxis News
over a month ago at gurufocus.com         
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635
Gurufocus Stories at Macroaxis
over a month ago at bizjournals.com         
Acquisition by Leonard Braden Michael of 206025 shares of Aclaris Therapeutics at 1.2443 subject to ...
bizjournals News
over a month ago at investing.com         
Aclaris stock boosted by BTIG on transformative AD drug acquisition and outlook
Investing News at Macroaxis
over three weeks ago at finance.yahoo.com         
Is There An Opportunity With IQVIA Holdings Inc.s 45 percent Undervaluation?
Yahoo News
over two months ago at zacks.com         
IQVIA Q3 Earnings Taking a Look at Key Metrics Versus Estimates
zacks News
over a week ago at finance.yahoo.com         
Is Medpace Stock Outpacing Its Medical Peers This Year?
Yahoo News
over two weeks ago at zacks.com         
Medpace Stock Moves -0.36 percent What You Should Know
zacks News
over a month ago at thelincolnianonline.com         
12,077 Shares in Medpace Holdings, Inc. Bought by Erste Asset Management GmbH
news
over a month ago at accesswire.com         
The Schall Law Firm Wants Shareholders To Join An Inquiry Into Medpace Holdings Inc For Violating Se...
news
over a week ago at gurufocus.com         
Icon PLC Celebrates a Year of Prestigious Awards and Recognitions
Gurufocus Stories at Macroaxis
over three weeks ago at simplywall.st         
At US219, Is ICON Public Limited Company Worth Looking At Closely?
Simply Wall St News at Macroaxis
over three weeks ago at finance.yahoo.com         
ICON Survey Highlights Sustained Investment in AI and Digital RD Innovation, Tempered by Siloed Adop...
Yahoo News
over a month ago at businesswire.com         
Glancy Prongay Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Publ...
businesswire News
over a month ago at gurufocus.com         
Sotera Health Co Q3 2024 Everything You Need To Know Ahead Of Earnings
Gurufocus Stories at Macroaxis
over a month ago at thelincolnianonline.com         
Sotera Health Issues FY24 Earnings Guidance
news
over a month ago at thelincolnianonline.com         
RadNet Shares Gap Up Whats Next?
news
over three weeks ago at cnbc.com         
The new hottest trade on Wall Street Quantum computing stocks
cnbc News
over a month ago at finance.yahoo.com         
Disposition of 5000 shares by Michael Murdock of RadNet subject to Rule 16b-3
Yahoo News
over three weeks ago at gurufocus.com         
Myriad Uranium Corp. to Present at the Precious Metals Critical Materials Virtual ...
Gurufocus Stories at Macroaxis
over a month ago at accesswire.com         
Myriad Genetics, Inc. Investigation Ongoing Contact Levi Korsinsky About Potential Securities Fraud ...
news
over a year ago at news.google.com         
BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Develo...
Google News at Macroaxis
over a month ago at news.google.com         
FONAR Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat
Google News at Macroaxis
over a month ago at finance.yahoo.com         
FONR Stock Gains Despite Q1 Earnings Dip and Rising Expenses
Yahoo News
over a month ago at www.macroaxis.com         
Disposition of 200000 shares by Nmsic Co-investment Fund, L.p. of Exagen at 3.3002 subject to Rule 1...
Macroaxis News
over a month ago at simplywall.st         
Exagen Third Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
Simply Wall St News at Macroaxis
over a month ago at gurufocus.com         
Exagen Inc Q3 2024 Earnings Call Highlights Navigating Challenges with Strategic Growth ...
Gurufocus Stories at Macroaxis
over two months ago at finance.yahoo.com         
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
Yahoo News
over a month ago at finance.yahoo.com         
Sera Prognostics Is In A Strong Position To Grow Its Business
Yahoo News
over a month ago at simplywall.st         
Have Sera Prognostics Insiders Been Selling Stock?
Simply Wall St News at Macroaxis
over a week ago at prnewswire.com         
LINDA YACCARINO, PRSIDENTE-DIRECTRICE GNRALE DE X CORP, SERA LINVITE DHONNEUR DU CES 2025
prnewswire News
over three weeks ago at news.google.com         
Burning Rock Biotechs Strategic Growth and Financial Results - Yahoo Finance
Google News at Macroaxis
over a week ago at gurufocus.com         
Burning Rock Biotech Stock Surges Amid Strategic Partnerships and Q3 Earnings
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Neogen that are available to investors today. That information is available publicly through Neogen media outlets and privately through word of mouth or via Neogen internal channels. However, regardless of the origin, that massive amount of Neogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Neogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neogen alpha.

Neogen Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insights Into Neogen Q1 Wall Street Projections for Key Metrics
10/07/2024
2
Acquisition by Boehm William T of 18653 shares of Neogen at 13.58 subject to Rule 16b-3
10/24/2024
3
Disposition of 38760 shares by John Adent of Neogen at 13.81 subject to Rule 16b-3
10/28/2024
4
Acquisition by Woteki Catherine E of 1776 shares of Neogen at 13.81 subject to Rule 16b-3
10/29/2024
5
Insider Trading
11/01/2024
6
Neogen Corp Trading Down 3.2 percent on Nov 12
11/12/2024
7
Why Neogen Chemicals Shaky Earnings Are Just The Beginning Of Its Problems
11/20/2024
8
Neogen to Participate in the 36th Annual Piper Sandler Healthcare Conference
11/27/2024
9
Neogen Co. Holdings Raised by Fred Alger Management LLC
11/29/2024
10
Neogen Corp Shares Gap Down to 13.205 on Dec 3
12/03/2024
11
Janus Henderson Group PLC Buys 1,843 Shares of Neogen Co.
12/06/2024
12
Veterinary Eye Care Market to Grow by USD 1.05 Billion , Report on AI-Powered Market Evolution and Rising Pet Ownership - Technavio
12/13/2024
13
Neogen Launches Petrifilm Bacillus cereus Count Plate to Enhance Food Safety Testing Efficiency
12/17/2024
14
Food Processing Distributor Nelson-Jameson Announces New Distribution Center in Fairview, Pennsylvania
12/20/2024
15
Heres Why Neogen Chemicals Has A Meaningful Debt Burden
12/26/2024

Complementary Tools for Neogen Stock analysis

When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon